Abstract
CD4+ T helper (TH) lymphocytes represent a heterogeneous population of cells that play an essential role in adaptive immunity. In addition to type 1 (TH1) and type 2 (TH2) cells, a third subset of CD4+ TH effector cells have recently been discovered and named as type 17 (TH17), because of its unique ability to produce interleukin (IL)-17. Studies in humans have demonstrated the plasticity of TH17 cells and their possibility to shift to cells producing IL-17A and IFN-γ or IL-17A and IL-4. The plasticity of TH17 to TH1 cells has recently been confirmed in mice, where it has been found that TH17 cells are pathogenic only after their shifting to TH1 cells. Human TH17 are also different from murine TH17 cells because all of them express CD161. They exclusively originate from CD161+ precursors present in umbilical cord blood and newborn thymus after their culturing in presence of IL-1β plus IL-23, and whereas TGF-β is not critical, it plays an indirect role in fostering their development.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acosta-Rodriguez EV, Rivino L, Geginat J, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 2007; 8:639–646.
Annunziato F, Cosmi L, Santarlasci V, et al. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 2007; 204:1849–1861.
Annunziato F, Romagnani S. Do studies in humans better depict Th17 cells? Blood. 2009; 114:2213–9.
Bending D, De La Peña H, Veldhoen M et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J. Clin. Invest. 2009; 119:565–572.
Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature. 2006; 44:235–238.
Chen Y, Thai P, Zhao YH, et al. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J. Biol. Chem. 2003; 278:17036–17043.
Chen Z, Tato CM, Muul L, Laurence A, O’Shea JJ. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum. 2007; 56:2936–2946.
Chung Y, Chang SH, Martinez GJ, et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity. 2009; 30:576–587.
Collison LW, and Vignali DA. Interleukin-35: odd one out or part of the family? Immunol Rev. 2008; 226:248–262.
Cosmi L, De Palma R, Santarlasci V, et al. Human interleukin-17-producing cells originate from a CD161+ CD4+ T-cell precursor. J. Exp. Med. 2008; 205:1903–1916.
Cosmi L, Maggi L, Santarlasci V et al. Identification of a novel subset of human circulating memory CD4+ T cells that produce both IL-17A and IL-4. Journal Allergy Clin. Immunol. 2010; 125:222–30.
Cua DJ, Sherlock J, Chen Y et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for auto-immune inflammation of the brain. Nature. 2003; 421:744–748.
Das J, Ren G, Zhang L, et al. Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation. J. Exp. Med. 2009; 206:2407–2416.
de Beaucoudrey L, Puel A, Filipe-Santos O et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J. Exp. Med. 2008 7; 205:1543–1550.
Doodes PD, Cao Y, Hamel KM et al. Development of proteoglycan-induced arthritis is independent of IL-17. J. Immunol. 2008; 181:329–337.
Dubin PJ, Kolls JK. Th17 cytokines and mucosal immunity. Immunol. Rev. 2008; 226:160–171.
Fouser LA, Wright JF, Dunussi-Joannopoulos K, et al. Th17 cytokines and their emerging roles in inflammation and auto-immunity. Immunol. Rev. 2008; 226:87–102.
Gately MK, Renzetti LM, Magram J et al. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 1998; 16:495–521.
Harris TJ, Grosso JF, Yen HR, et al. An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent auto-immunity. J. Immunol. 2007; 179:4313–4317.
Hofstetter HH, Ibrahim SM, Koczan D, et al. Therapeutic efficacy of IL-17 neutralization in murine experimental auto-immune encephalomyelitis. Cell. Immunol. 2005; 237:123–130.
Kao CY, Chen Y, Thai P, et al. IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J. Immunol. 2004. 173:3482–3491.
Kao CY, Huang F, Chen Y, Thaiet al. Up-regulation of CC chemokine ligand 20 expression in human airway epithelium by IL-17 through a JAK-independent but MEK/NF-kappaB-dependent signaling pathway. J. Immunol. 2005; 175:6676–6685.
Kisand K, Bøe Wolff AS, Podkrajsek KT, et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with auto-immunity to Th17-associated cytokines. J. Exp. Med. 2010; 207:299–308.
Kleinschek MA, Boniface K, Sadekova S, et al. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J. Exp. Med. 2009; 206:525–534.
Komiyama Y, Nakae S, Matsuki T, et al. IL-17 plays an important role in the development of experimental auto-immune encephalomyelitis. J. Immunol. 2006; 177:566–573.
Korn T, Bettelli E, Gao W, et al. IL-21 initiates an alternative pathway to induce pro-inflammatory T(H)17 cells. Nature. 2007; 448:484–487.
Kroenke MA, Carlson TJ, Andjelkovic AV, et al. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 2009; 205:1535–1541.
Lanier LL, Chang C, Philips JH. Human NKR-P1A. A disulphide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J. Immunol.1994; 153:2417–2428.
Laurence A, O’Shea JJ. T(H)-17 differentiation: of mice and men. Nat Immunol. 2007;8:903–905.
Lee YK, Turner H, Maynard CL, et al. Late developmental plasticity in the T helper 17 lineage. Immunity. 2009; 30:92–107.
Leonardi CL, Kimball AB, Papp KA, et al. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet. 2008; 371:1665–1674.
Liu Y, Yang B, Zhou M, et al. Memory IL-22-producing CD4+ T cells specific for Candida albicans are present in humans. Eur. J. Immunol. 2009; 39:1472–1479.
Luger D, Silver PB, Tang J, et al. Either a Th17 or a Th1 effector response can drive auto-immunity: conditions of disease induction affect dominant effector category. J. Exp. Med. 2008; 205: 799–810.
Ma CS, Chew GY, Simpson N, et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J. Exp. Med. 2008; 205:1551–1557.
Manel N, Unutmaz D, Littman DR. The differentiation of human Th17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt. Nat. Immunol. 2008; 9:641–649.
Mangan PR, Harrington LE, O’Quinn, et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature. 2006; 441:231–234.
Marks BR, Nowyhed HN, Choi JY, et al. Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation. Nat. Immunol. 2009; 10:1125–1132.
Martin-Orozco N, Chung Y, Chang SH, et al. Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur. J. Immunol. 2009; 39:216–24.
Mosmann TR, Cherwinski C, Bond MW, et al. Two types of murine helper T cell clones. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986; 136: 2348–2357.
Nurieva R, Yang XO, Martinez G, et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature. 2007; 448:480–483.
Ogawa A, Andoh A, Araki Y, et al. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin. Immunol. 2004; 110:55–62.
Ouyang W, Koli JK, and Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity. 2008; 28:454–467.
Papp KA, Langley RG, Lebwohl M, et al. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2). Lancet. 2008; 371:1675–1684.
Pelletier M., Maggi L, Micheletti A, et al., Evidence for a cross-talk between human neutrophils and Th17 cells. Blood. 2010; 115:335–343.
O’Garra A, Stockinger B, Veldhoen M. Differentiation of human T(H)-17 cells does require TGF-beta! Nat. Immunol. 2008; 9:588–90.
Oppman B, Lesley R, Blom B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000; 13:715–725.
Peck A, Mellins ED. Precarious balance: Th17 cells in host defense. Infect. Immun. 2010; 78:32–38.
Puel A, Döffinger R, Natividad A, et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and auto-immune polyendocrine syndrome type I. J. Exp. Med. 2010; 207:291–297.
Romagnani S. Human TH1 and TH2 subsets: doubt no more. Immunol Today 1991;12:256–257.
Romagnani S. The Th1/Th2 paradigm. Immunol. Today. 1997; 18:263–266.
Santarlasci V, Maggi L, Capone M et al. TGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cells. Eur. J. Immunol. 2009;39: 207–215.
Tato CM, Laurence A, O’Shea JJ. J Helper T cell differentiation enters a new era: le roi est mort; vive le roi! J. Exp. Med. 2006; 203:809–812.
van Beelen AJ, Zelinkova Z, Taanman-Kueter EW et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity. 2007a; 27:660–669.
van Beelen AJ, Teunissen MB, Kapsenberg ML, de Jong EC. Interleukin-17 in inflammatory skin disorders. Curr. Opin. Allergy Clin. Immunol. 2007b; 7:374–381
Veldhoen M, Hocking RJ, Atkins CJ, et al. TGF-beta in the context of an inflammatory cytokine milieu supports differentiation of IL-17-producing T cells. Immunity. 2006; 25:179–189.
Volpe E, Servant N, Zollinger R, et al. A critical function for transforming growth factor-β, interleukin-23 and pro-inflammatory cytokines in driving and modulating human Th17 responses. Nat. Immunol. 2008; 9: 650–657.
Wilson NJ, Boniface K, Chan JR, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 2007; 8:950–957.
Yang L, Anderson DE, Baecher-Allan C, et al. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature. 2008; 454:350–352.
Yao Z, et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity. 1995; 3:811–821.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Annunziato, F., Cosmi, L., Liotta, F., Maggi, E., Romagnani, S. (2011). Human TH17 Cells. In: Jiang, S. (eds) TH17 Cells in Health and Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9371-7_12
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9371-7_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-9370-0
Online ISBN: 978-1-4419-9371-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)